MLYS — MINERALYS THERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in MINERALYS THERAPEUTICS INC (MLYS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.74% (2025 Q2)
Avg. % of fund
1.4%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 290,049 +131,937 +83.4% 1.80% $10.5M $36.29
2025 Q3 REDUCED 158,112 -473,474 -75.0% 1.20% $6.0M $37.92
2025 Q2 ADDED 631,586 +506,586 +405.3% 2.74% $8.6M $13.53
2025 Q1 REDUCED 125,000 -275,101 -68.8% 0.03% $94K $15.88
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MLYS price (monthly, adj. close)

Other funds also holding MLYS

As of 2025 Q4 — sorted by position size

Catalys Pacific, LLC 92.37% Andera Partners 32.71% Samsara BioCapital, LLC 3Y 7Y 21.98% Caligan Partners LP 3Y 8.28% SR ONE CAPITAL MANAGEMENT, LP 3Y 8.03% Caligan Partners LP 3Y 6.87% 22NW, LP 3Y 7Y 5.47% Buckley Capital Advisors, LLC 4.45% Velan Capital Investment Management LP 3Y 3.18% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 3.15%
← Back to STEMPOINT CAPITAL LP Holdings